Figure 1: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 2: Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
Figure 3: Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 5: Genomic Cancer Panel and Profiling Market: Research Methodology
Figure 6: Primary Research Methodology
Figure 7: Bottom-Up Approach (Segment-Wise Analysis)
Figure 8: Top-Down Approach (Segment-Wise Analysis)
Figure 9: Genomic Cancer Panel and Profiling Workflow, End User Perspective
Figure 10: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
Figure 11: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 12: General Testing Criterion According to the NCCN Guidelines
Figure 13: Reimbursement Components in the U.S.
Figure 14: Genomic Cancer Panel and Profiling Market, Patent Analysis (by Year), January 2020-October 2023
Figure 15: Genomic Cancer Panel and Profiling Market, Patent Analysis (by Country), January 2020-October 2023
Figure 16: Genomic Cancer Panel and Profiling Market Dynamics
Figure 17: Cancer Profiling Cases in Developed Countries
Figure 18: Share of Global Cancer Prevalence, 2010-2019
Figure 19: Share of Global Age-Standardized Death Rate of Cancer, 2010-2019
Figure 20: Genomic Research Funding by National Human Genome Research Institute (NHGRI), $Million, 2020, 2021, and 2022
Figure 21: Key Players Offering
Figure 22: Reimbursement Reductions Adopted for Oncology Testing as per PAMA Revisions
Figure 23: Cost Difference between the Multi-Gene Panel Test and Usual Care Screening Test
Figure 24: Share of Key Developments, January 2020-October 2023
Figure 25: Number of Product Launches, Approvals, and Upgradations (by Company), January 2020-October 2023
Figure 26: Growth-Share Analysis of the Genomic Cancer Panel and Profiling Market (by Technology), 2022
Figure 27: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
Figure 28: Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 29: Europe Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
Figure 30: Europe Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
Figure 31: Europe Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
Figure 32: Germany Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 33: France Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 34: U.K. Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 35: Italy Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 36: Spain Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 37: Rest-of-Europe Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
Figure 38: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
Figure 39: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 40: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2020-2022
Figure 41: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2020-2022
Figure 42: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2020-2022